<DOC>
	<DOCNO>NCT01209793</DOCNO>
	<brief_summary>This study conduct assess safety tolerability single ascend intravenous ( IV ) dose REGN846 healthy volunteer .</brief_summary>
	<brief_title>Safety Tolerability Study REGN846 ( SAR302352 ) Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy men woman age 18 65 ; woman must postmenopausal surgically sterile Body Mass Index ( BMI ) 18.0 30.0 kg/m2 , inclusive Normal vital sign rest sit position 5 minute : Normal standard 12lead ECG Willing able comply clinic visit studyrelated procedure Provide sign informed consent Able understand complete studyrelated questionnaire Current prior history smoke Any illness condition would adversely affect subject 's participation study Hospitalization within 60 day screen visit Any clinically significant abnormality observe screen visit History positive human immunodeficiency virus ( HIV ) screen result screen visit History positive blood test hepatitis B/hepatitis C positive hepatitis screen result screen visit History positive drug screen result drug alcohol abuse within year prior screening visit Known sensitivity component Investigational Product formulation Participation clinical research study evaluate another investigational drug therapy within 30 day least 5 halflives ( whichever longer ) , investigational drug prior screen visit Any condition would place subject risk , interfere participation study History parasitic infection recent ( within previous 6 month ) travel parasitic endemic area Live/attenuated vaccination within 12 week screen study Any subject plan elective surgery Sexually active men unwilling utilize adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>